Insider Actions for Protagonist Therapeutics Inc.
01/16/2023 |
Suneel Gupta Chief Development Officer |
20,625 | Award at $0 per share. | 0 |
01/16/2023 |
Arturo Molina Chief Medical Officer |
3,125 | Award at $0 per share. | 0 |
01/16/2023 |
Asif Ali Chief Financial Officer |
10,625 | Award at $0 per share. | 0 |
12/28/2022 |
Dinesh V. Patel President and CEO; Director |
3,116 | Gift at $0 per share. | 0 |
11/16/2022 |
David Y. Liu Chief R&D Strategy Officer |
35,331 | Derivative/Non-derivative trans. at $4.21 per share. | 148,743 |
11/16/2022 |
David Y. Liu Chief R&D Strategy Officer |
35,656 | Derivative/Non-derivative trans. at $1.16 per share. | 41,360 |
11/16/2022 |
David Y. Liu Chief R&D Strategy Officer |
5,999 | Derivative/Non-derivative trans. at $1.89 per share. | 11,338 |
11/16/2022 |
David Y. Liu Chief R&D Strategy Officer |
9,726 | Derivative/Non-derivative trans. at $1.89 per share. | 18,382 |
11/16/2022 |
David Y. Liu Chief R&D Strategy Officer |
13,767 | Derivative/Non-derivative trans. at $0.87 per share. | 11,977 |
11/15/2022 |
Arturo Molina Chief Medical Officer |
21,250 | Award at $0 per share. | 0 |
08/23/2022 |
Dinesh V. Patel President and CEO; Director |
20,000 | Derivative/Non-derivative trans. at $4.21 per share. | 84,200 |
05/04/2022 |
Dinesh V. Patel President and CEO; Director |
3,000 | Gift at $0 per share. | 0 |
05/04/2022 |
Dinesh V. Patel President and CEO; Director |
15,742 | Derivative/Non-derivative trans. at $4.21 per share. | 66,273 |
05/03/2022 |
William D. Waddill Director |
12,000 | Derivative/Non-derivative trans. at $8.59 per share. | 103,080 |
04/26/2022 |
Dinesh V. Patel President and CEO; Director |
30,000 | Derivative/Non-derivative trans. at $4.21 per share. | 126,300 |
04/26/2022 |
Suneel Gupta Chief Development Officer |
40,000 | Derivative/Non-derivative trans. at $7.38 per share. | 295,200 |
04/18/2022 |
Asif Ali Chief Financial Officer |
13,750 | Award at $0 per share. | 0 |
04/14/2022 |
Dinesh V. Patel President and CEO; Director |
34,087 | Derivative/Non-derivative trans. at $1.89 per share. | 64,424 |